Title:
【発明の名称】ウイルスのヌクレオチド配列
Document Type and Number:
Japanese Patent JP3292371
Kind Code:
B2
Abstract:
A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK<-> or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
Inventors:
Griffin, anette mary
Ross, Louise Joseph Norman
Scott, Simon David
Binz, Matthew McKinley
Ross, Louise Joseph Norman
Scott, Simon David
Binz, Matthew McKinley
Application Number:
JP50949989A
Publication Date:
June 17, 2002
Filing Date:
September 13, 1989
Export Citation:
Assignee:
Merial
International Classes:
A01K67/027; A61K31/00; A61K35/76; A61K39/12; A61K39/215; A61K39/245; A61K39/255; A61K39/265; A61K39/275; A61K39/295; A61K48/00; A61P31/00; A61P31/12; A61P31/20; A61P31/22; A61P37/04; C07K14/00; C07K14/005; C07K14/03; C07K14/035; C07K14/055; C07K14/195; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N7/00; C12N7/01; C12N7/04; C12N9/02; C12N9/12; C12N15/00; C12N15/09; C12N15/33; C12N15/38; C12N15/45; C12N15/86; C12N15/869; C12P21/02; A61K38/00; A61K39/00; C12R1/91; C12R1/92; C12N; (IPC1-7): C12N15/09; A61K39/255; C12N7/00; C12R1:92
Other References:
Ｊｏｕｒｎａｌ ｏｆ Ｖｉｒｏｌｏｇｙ，Ｖｏｌ．５３，Ｎｏ．１，（１９８５），Ｐ．２４３−２５３
Ｍｉｃｒｏｂｉｏｌ．Ｉｍｍｕｎｏｌ．，Ｖｏｌ．２８，Ｎｏ．８，（１９８４），Ｐ．９２３−９３３
Ｐｒｏｃ．Ｎａｔｌ．Ａｃａｄ．Ｓｃｉ．ＵＳＡ，Ｖｏｌ．８４，Ｎｏ．１６（１９８７），Ｐ．５９０８−５９１２
Ｍｉｃｒｏｂｉｏｌ．Ｉｍｍｕｎｏｌ．，Ｖｏｌ．２８，Ｎｏ．８，（１９８４），Ｐ．９２３−９３３
Ｐｒｏｃ．Ｎａｔｌ．Ａｃａｄ．Ｓｃｉ．ＵＳＡ，Ｖｏｌ．８４，Ｎｏ．１６（１９８７），Ｐ．５９０８−５９１２
Attorney, Agent or Firm:
Takashi Koshiba